Contact Address

#B-1 & B-2, KSSIDC, Veerasandra Industrial Area Stage 1, Electronic City Phase 2, Bengaluru - 560100, Karnataka, India

Contact Info

Looking Beyond Antibody Titers in Modern Vaccine Development?

The science of vaccine development has evolved significantly. While neutralizing antibodies remain important, they no longer tell the complete story of vaccine performance.

Today’s next-generation vaccines are evaluated based on their ability to generate robust cellular immunity, durable memory responses, and balanced immune activation. Understanding the complete immunological profile has become essential for demonstrating vaccine efficacy, durability, and safety.

At ImmunitasBio, we provide advanced Vaccine Immunogenicity Testing Services that help vaccine developers understand how the immune system responds to their candidates from early preclinical studies through clinical trials.

Our integrated platforms combine Cellular Immunity Assessment, Humoral Immunity Profiling, and Vaccine Safety Evaluation to generate high-resolution immune response data that supports informed development decisions.

Why Is Comprehensive Vaccine Immune Response Analysis Important?

Successful vaccines must do more than generate antibodies.
Developers need answers to critical questions:

Does the vaccine activate antigen-specific T cells?
How durable is the immune response?
Are memory B cells being generated?
Is the immune response balanced?
Are there any safety concerns related to immune polarization?
Can long-term protection be predicted?

Our Vaccine Research Services help answer these questions through advanced immunology platforms and scientifically validated assays.

Cellular Immunity Assessment & Deep T-Cell Profiling

Cell-mediated immunity plays a crucial role in vaccine effectiveness, particularly for infectious diseases and emerging vaccine technologies.
Antigen-Specific Functional T-Cell Assessment
Using high-sensitivity ELISpot platforms, we quantify vaccine-induced T-cell responses by measuring:

IFN-γ secreting cells
IL-2 responses
IL-4 production
IL-17 responses
CD4+ T-cell activity
CD8+ T-cell responses

These assays enable detection of low-frequency antigen-specific immune responses that may not be identified using traditional methods.

Deep T-Cell Profiling (AIM Assay)

Our Activation Induced Marker (AIM) assays provide detailed characterization of vaccine-responsive T cells through multiparameter flow cytometry.

We evaluate:

CD4+ and CD8+ T-cell activation
OX40 expression
CD137 expression
CD69 activation markers
Memory T-cell populations
Effector T-cell subsets
T-cell exhaustion markers

This provides a deeper understanding of vaccine-induced cellular immunity.

Humoral Immunity Profiling & Vaccine Durability Assessment

While cellular immunity is critical, understanding antibody-producing B-cell responses remains an essential component of vaccine evaluation.
Active Humoral Response Profiling
Our B-cell ELISpot platform enables:

Direct enumeration of antigen-specific antibody-secreting cells
Monitoring of early vaccine responses
IgG profiling
IgA profiling
IgM profiling
Plasmablast response analysis

These studies provide insights into immediate post-vaccination immune activation.

Vaccine Durability & Memory B-Cell Assessment

Long-term protection depends on immune memory.
Our Vaccine Durability Studies assess:

Antigen-specific memory B-cell frequencies
Longitudinal immune monitoring
Memory B-cell phenotype characterization
Isotype-specific memory responses
Predictive correlates of long-term protection

These analyses help developers understand how long vaccine-induced immunity may persist.

Vaccine Safety Testing & Immune Polarization Profiling

A strong immune response is valuable only when it is appropriately balanced.
Our Vaccine Safety Testing Services evaluate:

Vaccine-Associated Enhanced Disease (VAED) risk assessment
Th1 immune responses
Th2 immune responses
Th17 immune responses
Cytokine response mapping
Immune polarization analysis
Vaccine-Associated Enhanced Disease (VAED) risk assessment

Using ELISpot and Luminex platforms, we generate comprehensive immune safety profiles that support regulatory and clinical development programs.

The ImmunitasBio Advantage

We are more than a testing laboratory.
As a scientific partner for vaccine developers, we provide:

Bespoke Assay Development

Customized assays tailored to specific antigens, peptide pools, and vaccine platforms.

Advanced Immunology Platforms

State-of-the-art ELISpot, Flow Cytometry, and Luminex technologies.

Expert Scientific Guidance

Interpretation of complex immune response data and regulatory-ready reporting.

End-to-End Vaccine Development Support

Support from preclinical vaccine research through clinical immune monitoring.

Partner with ImmunitasBio for Vaccine Research & Immunogenicity Testing

Whether you are developing prophylactic vaccines, therapeutic vaccines, mRNA platforms, protein-based vaccines, or next-generation immunization technologies, ImmunitasBio provides the scientific expertise and immune profiling capabilities needed to accelerate development and improve confidence in your data.

Partner with us

Frequently Asked Questions

What are Vaccine Immunogenicity Testing Services?

Vaccine Immunogenicity Testing Services evaluate how effectively a vaccine stimulates the immune system by measuring cellular, humoral, and memory immune responses.

Cellular immunity helps determine how effectively T cells respond to vaccine antigens and contributes to long-term protection against disease.

A T-Cell ELISpot Assay measures antigen-specific T-cell responses by detecting cytokine-secreting immune cells after stimulation with vaccine antigens.

Deep T-Cell Profiling uses multiparameter flow cytometry to characterize activated, memory, effector, and antigen-specific T-cell populations.

Humoral Immunity Profiling measures antibody-producing B-cell responses, including IgG, IgA, and IgM production following vaccination.

Memory B-cell analysis helps predict long-term vaccine durability and the ability of the immune system to respond to future exposures.

Vaccine Durability Studies evaluate how long vaccine-induced immunity persists by monitoring memory B-cell and antibody responses over time.

Immune Polarization Profiling evaluates Th1, Th2, and Th17 immune responses to ensure balanced immunity and identify potential safety concerns.

VAED is a potential adverse immune response where vaccination may worsen disease outcomes. Specialized immune profiling helps assess and mitigate this risk.

Common platforms include ELISpot, Flow Cytometry, Luminex, multiplex cytokine analysis, and memory B-cell assays.

Yes. ImmunitasBio supports vaccine developers from preclinical research through clinical immune monitoring and immunogenicity evaluation.

ImmunitasBio combines advanced immunology expertise, bespoke assay development, state-of-the-art platforms, and scientific partnership to help developers generate actionable immune response data.